DrugPatentWatch Database Preview

Details for Patent: 8,003,679

« Back to Dashboard

Which drugs does patent 8,003,679 protect, and when does it expire?

Patent 8,003,679 protects MICARDIS and is included in one NDA.

This patent has forty-one patent family members in eighteen countries.

Summary for Patent: 8,003,679

Title:	Use of inhibitors of the renin-angiotensin system
Abstract:	Inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia, such as stroke.
Inventor(s):	Montgomery; Hugh Edward (London, GB), Martin; John Francis (London, GB), Erusalimsky; Jorge Daniel (London, GB)
Assignee:	ArkTherapeutics Group, plc (London, GB)
Application Number:	11/441,648
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 8,003,679

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Boehringer Ingelheim	MICARDIS	telmisartan	TABLET;ORAL	020850-002	Nov 10, 1998	AB	RX	Yes	Yes						TREATMENT OR PREVENTION OF STROKE

International Family Members for US Patent 8,003,679

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
African Regional IP Organization (ARIPO)	1300
Austria	294579
Austria	366110
Australia	742506
Australia	9453398
Canada	2306216
Canada	2677910